The stock of Aspira Women’s Health Inc (AWH) has gone down by -12.12% for the week, with a -12.12% drop in the past month and a -58.57% drop in the past quarter. The volatility ratio for the week is 14.84%, and the volatility levels for the past 30 days are 22.46% for AWH. The simple moving average for the last 20 days is 8.57% for AWH stock, with a simple moving average of -58.26% for the last 200 days.
Is It Worth Investing in Aspira Women’s Health Inc (NASDAQ: AWH) Right Now?
The 36-month beta value for AWH is also noteworthy at 1.54. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for AWH is 8.82M, and at present, short sellers hold a 3.05% of that float. The average trading volume of AWH on July 24, 2024 was 108.70K shares.
AWH) stock’s latest price update
Aspira Women’s Health Inc (NASDAQ: AWH)’s stock price has decreased by -5.84 compared to its previous closing price of 1.54. However, the company has seen a -12.12% decrease in its stock price over the last five trading sessions. globenewswire.com reported 2024-07-09 that AUSTIN, Texas, July 09, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that it has closed its previously announced private placement for the issuance and sale of shares of the Company’s common stock and accompanying warrants to purchase an equal number of shares for gross proceeds of approximately $1.9 million. Aspira has the potential to receive additional gross proceeds of up to $2.8 million, before deducting offering expenses, upon the full cash exercise of warrants issued in the private placement.
Analysts’ Opinion of AWH
Many brokerage firms have already submitted their reports for AWH stocks, with Cantor Fitzgerald repeating the rating for AWH by listing it as a “Overweight.” The predicted price for AWH in the upcoming period, according to Cantor Fitzgerald is $4 based on the research report published on January 12, 2022 of the previous year 2022.
Truist, on the other hand, stated in their research note that they expect to see AWH reach a price target of $12. The rating they have provided for AWH stocks is “Buy” according to the report published on March 29th, 2021.
Cantor Fitzgerald gave a rating of “Overweight” to AWH, setting the target price at $10 in the report published on January 29th of the previous year.
AWH Trading at -24.08% from the 50-Day Moving Average
After a stumble in the market that brought AWH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.52% of loss for the given period.
Volatility was left at 22.46%, however, over the last 30 days, the volatility rate increased by 14.84%, as shares sank -11.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -52.77% lower at present.
During the last 5 trading sessions, AWH fell by -12.12%, which changed the moving average for the period of 200-days by -71.00% in comparison to the 20-day moving average, which settled at $1.3265. In addition, Aspira Women’s Health Inc saw -64.46% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AWH starting from Sandford Nicole, who purchase 9,493 shares at the price of $2.42 back on May 31 ’24. After this action, Sandford Nicole now owns 70,596 shares of Aspira Women’s Health Inc, valued at $22,973 using the latest closing price.
Sandford Nicole, the President & CEO of Aspira Women’s Health Inc, purchase 5,000 shares at $3.36 during a trade that took place back on Dec 06 ’23, which means that Sandford Nicole is holding 58,703 shares at $16,800 based on the most recent closing price.
Stock Fundamentals for AWH
Current profitability levels for the company are sitting at:
- -1.92 for the present operating margin
- 0.59 for the gross margin
The net margin for Aspira Women’s Health Inc stands at -1.64. The total capital return value is set at -9.24. Equity return is now at value -701.30, with -158.00 for asset returns.
Based on Aspira Women’s Health Inc (AWH), the company’s capital structure generated 2.63 points at debt to capital in total, while cash flow to debt ratio is standing at -6.64. The debt to equity ratio resting at -1.61. The interest coverage ratio of the stock is 557.48.
Currently, EBITDA for the company is -18.65 million with net debt to EBITDA at 0.04. When we switch over and look at the enterprise to sales, we see a ratio of 2.22. The receivables turnover for the company is 5.87for trailing twelve months and the total asset turnover is 1.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.16.
Conclusion
In summary, Aspira Women’s Health Inc (AWH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
